Regulation

Idaho Medical Cannabis Ballot Bid Ends Without a Court Fight

mm
Add MyCannabis.com to your preferred sources on Google

Idaho will remain one of the few states that criminalizes cannabis in every form, after the campaign behind a 2026 medical legalization initiative said it will not fight the state’s decision to disqualify most of its petition signatures. The move ends this cycle’s push to put medical cannabis before Idaho voters, and it hands new weight to a separate November vote that could close off the citizen-initiative route for good.

The Natural Medicine Alliance of Idaho gathered more than 150,000 signatures ahead of the May 1, 2026 filing deadline, roughly double what it needed. But Idaho Secretary of State Phil McGrane’s office determined on July 14, 2026 that only 58,024 were valid, a rejection rate of about 61%. In a July 17, 2026 letter to McGrane, the group’s attorney disputed several of the state’s findings but confirmed the campaign would not pursue a legal challenge, closing the book on the effort.

The shortfall was not marginal. To reach the ballot, an Idaho initiative needs valid signatures equal to 6% of registered voters statewide, or 70,725 this cycle, and it must clear that same 6% mark in at least 18 of the state’s 35 legislative districts. The medical cannabis measure missed on both counts: it fell 12,701 signatures short statewide and hit the 6% threshold in only 13 districts, five fewer than required, according to the secretary of state’s letter as reported by the Idaho Capital Sun. McGrane’s office said that even under the most favorable assumptions about timing and validity, the campaign still would not have qualified.

A dispute the campaign won’t take to court

The group argued the rejection rate was abnormally high. Its attorney, Jeremy Chou of Givens Pursley LLP, wrote that more than 10,000 signatures from registered voters were discarded “based on technicalities or legally questionable grounds.”

Chou pointed to three practices in particular: clerks rejecting an entire sheet when a voter signed one assigned to a different county; voiding undated signatures even where the date was obvious from the circulator’s sworn affidavit; and striking signatures from voters later flagged as inactive. He argued none of those rules is clearly compelled by Idaho’s initiative statutes. Still, the alliance chose to make its argument in a letter rather than a courtroom, having said in the days after the ruling that it was reviewing every legal and procedural remedy available.

McGrane’s office had raised concerns of its own. It said it could not verify the residency of 293 people who circulated petitions, and Idaho law requires circulators to be state residents. The office also referred possible fraud to the Idaho State Police, including a signature attributed to a voter whom state records show died in 2021. The campaign blamed its first signature-gathering vendor for the breakdowns; that firm, Black Peak, publicly defended its work and said the alliance had declined to pay its bill. The same review cycle that sank the cannabis measure certified a separate abortion-rights initiative for the November ballot, a reminder that the state’s threshold is reachable when a signature drive holds together.

Why 2026 may have been the best shot

Idaho is one of the few states with no medical cannabis program of any kind. The proposed Idaho Medical Cannabis Act would have let patients with conditions such as cancer, epilepsy, Crohn’s disease, or post-traumatic stress obtain a medical card, with a regulated supply served initially by a small number of licensed, vertically integrated operators. The campaign was started by friends and family of Dori Tunney, a Boise-area pediatrician who died of brain cancer in 2024 after cannabis eased her treatment; donors tied to her family reportedly contributed more than $3 million, which the group used to hire professional signature-gatherers.

The defeat also raises the stakes on a measure lawmakers already placed on the November 3, 2026 ballot. That constitutional amendment would give the Legislature, not voters, sole authority to legalize cannabis or other controlled substances. If it passes, future citizen initiatives on cannabis would carry no legal force, making this year’s drive potentially the last viable ballot path to medical access.

Idaho lawmakers have resisted both routes for years. The Legislature formally urged voters to reject the medical measure, and it has repeatedly tried to tighten the initiative process; the Idaho Supreme Court struck down one such attempt in 2021, calling the initiative and referendum powers fundamental rights reserved to the people. More than a decade of cannabis petition drives in the state has ended the same way, without a single measure reaching the ballot. Other conservative states have gone the opposite direction: Nebraska voters approved a medical cannabis program at the ballot box, the very mechanism Idaho may soon close off.

For now, Idaho patients have neither a program nor a live initiative. Whether they keep even the right to ask again will be decided by how voters answer the November amendment.

Ava Morales is an AI-generated analyst at MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.